Evome Medical Technologies Announces Securities Issuances
Evome Medical Technologies Announces Securities Issuances
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the "TSXV") to complete a shares for services transaction with Beacon Securities Limited ("Beacon") pursuant to which the Company will issue Beacon 504,286 common shares of the Company at a deemed price of $0.1983 per share in satisfaction of $100,000 of advisory services. The shares issuable will be subject to a Canadian four-month hold period.
Evome Medical Technologies Inc.（"公司"或"Evome"）（TSXV：EVMT）於2024年6月14日（環球新聞社）宣佈獲得了來自TSX Venture Exchange（"TSXV"）的有條件批准，以完成與Beacon Securities Limited（"Beacon"）的股份交易，根據該交易，公司將以每股0.1983美元的價格發行504,286股普通股，用於支付100,000美元的諮詢服務費。可發行股份將受到加拿大四個月的持有期限限制。
In addition, the directors of the Company have granted 100,000 stock options and 3,700,000 restricted stock units to certain eligible participants under the Company's 2023 Equity Incentive Plan. The options are exercisable at $0.105 for five years and vest over twenty-four months, and the restricted stock units shall vest over twenty-four months and settle in common shares of the Company. The awards and underlying common shares are subject to a four month and one day hold period pursuant to Canadian securities laws and the TSXV.
此外，公司董事會已授予100,000股期權和3,700,000限制性股票給公司2023年股權激勵計劃的某些合格參與者。這些期權的行權價格爲0.105美元，有效期爲五年，並在24個月內分期歸屬，限制性股票將在24個月內分期歸屬並以公司普通股結算。該獎項和基礎普通股受加拿大證券法和TSXV規定的四個月加一天的持有期限限制。
Mike Seckler
Chief Executive Officer
Tel: 1 (800) 760-6826
Email: Info@Salonaglobal.com
Mike Seckler
首席執行官
電話：1（800）760-6826
電子郵件：Info@Salonaglobal.com
Cautionary Statements
警示聲明
Unless otherwise specified, all financial information is presented in Canadian dollars ("$", "dollars" and "C$").
除非另有說明，所有財務信息均以加元（“$”，“dollars”和“C $”）表示。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
tsxv的監管服務提供商（在其政策中定義該術語）對本公告的充分性或準確性不承擔責任。
譯文內容由第三人軟體翻譯。